Dr Reddys American Depository Receipts listed on NSE International Exchange

Published On 2020-12-11 06:41 GMT   |   Update On 2020-12-11 06:41 GMT

Hyderabad and Princeton: Dr. Reddy's Laboratories Ltd. has recently announced the secondary listing of its American Depository Receipts (ADRs) on NSE IFSC Limited under the symbol 'DRREDDY' on December 9, 2020. NSE IFSC Limited is a recognized international stock exchange established in the International Financial Services Centre ("IFSC"), GIFT City Gujarat, India. IFSC is one of...

Login or Register to read the full article

Hyderabad and Princeton: Dr. Reddy's Laboratories Ltd. has recently announced the secondary listing of its American Depository Receipts (ADRs) on NSE IFSC Limited under the symbol 'DRREDDY' on December 9, 2020.

NSE IFSC Limited is a recognized international stock exchange established in the International Financial Services Centre ("IFSC"), GIFT City Gujarat, India. IFSC is one of the permissible jurisdictions where Depository Receipts can be listed on Framework for issuance of Depository Receipts and IFSC Authority on Depository Receipts in the IFSC.

The said listing will provide a secondary platform (other than NYSE Inc.) to overseas investors for trading in Dr. Reddy's ADRs. This is a secondary listing of ADRs that are currently issued by J.P. Morgan Chase Bank N.A. under its ADR Deposit agreement with Dr. Reddy's, and no further capital raising or issuance of new securities is involved. The clearing and settlement of ADRs will be done by NSE IFSC Clearing Corporation Limited through depository account maintained with Clearstream using Internal (Clearstream to Clearstream), Bridge (Clearstream-Euroclear) and Clearstream Domestic links to American market for settlement with Depository Trust Company (DTC) US settlement systems.

Read also: Dr Reddys, RDIF begin Sputnik V clinical trials in India

Dr. Reddy's Laboratories Ltd. is an integrated pharmaceutical company headquartered in Hyderabad, committed to providing affordable and innovative medicines for healthier lives.

Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology.



Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News